摘要
目的:探索肌电生物反馈联合任务序列训练对脑卒中偏瘫患者步行能力障碍影响。方法:以2019年5月至2022年3月于我院进行治疗的脑卒中偏瘫患者102例为研究对象,随机分为试验组和对照组,各51例。对照组采用肌电生物反馈治疗,试验组在此基础上结合任务序列训练治疗。综合比较两组患者干预前后步行能力(MAS量表评分、FAC量表评分、FMA量表评分、踝关节主动背伸活动度)、下肢肌力(胫骨前肌和腓肠肌的积分肌电值)及生活质量(生活质量SF-36量表评分、Barthel指数量表评分)。结果:干预后试验组MAS量表评分、FAC量表评分、FMA量表评分、踝关节主动背伸活动度均显著高于对照组(P<0.05);试验组主动运动时胫骨前肌的积分肌电值高于对照组(109.92±18.36 vs 89.41±10.35,P<0.05),腓肠肌积分肌电值低于对照组(8.39±2.03 vs 13.04±1.87,P<0.05);同时试验组SF-36量表评分、Barthel指数量表评分均显著高于对照组(P<0.05)。结论:脑卒中偏瘫患者经过肌电生物反馈联合任务序列训练可有效改善小腿肌肉异常,改善步行运动能力,提高生活质量。
Objective:To explore the effects of EMG biofeedback combined with task-oriented circuit therapy for walking impairment in stroke patients with hemiplegia.Methods:A total of 102 stroke patients with hemiplegia in our hospital from May 2019 to March 2022 were randomly divided into experiment group and control group,21 cases in each group.EMG biofeedback was used in control group while EMG biofeedback combined with task-oriented circuit therapy was used in experiment group.The walking ability,leg myodynamia and life quality were recorded and compared.Results:After treatment,the MAS score,FAC score,FMA score and active dorsal expansion ROM of ankle joint in experiment group were significantly higher than those in control group(P<0.05).the EMG value of tibialis anterior muscle in experiment group was significantly higher than that in control group(109.92±18.36 vs 89.41±10.35,P<0.05),while the EMG value of gastrocnemius muscle in experiment group was significantly lower than that in control group(8.39±2.03 vs 13.04±1.87,P<0.05).The experiment group also had significantly higher SF-36 scale scores and Barthel Index scale scores than the control group(P<0.05).Conclusion:The EMG biofeedback combined with task-oriented circuit therapy in stroke patients with hemiplegia can improve myodynamia of shank,enhance walking ability and life quality.
作者
谭建
吴小燕
张巧荣
崔莉茹
贾胜男
杨傲然
张亚楠
TAN Jian;WU Xiaoyan;ZHANG Qiaorong(Beijing Rehabilitation Hospital,Capital Medical University,Beijing 100144,China)
出处
《河北医学》
CAS
2022年第9期1469-1473,共5页
Hebei Medicine
基金
国家重点研发计划课题项目,(编号:2020YFC2004303)。